614 related articles for article (PubMed ID: 15773501)
1. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
2. [Characteristic of clinical strains of gram-negative obligate anaerobes].
Kadzielska J; Kierzkowska M; Sawicka-Grzelak A; Rokosz A; Łuczak M
Med Dosw Mikrobiol; 2007; 59(4):351-7. PubMed ID: 18416127
[TBL] [Abstract][Full Text] [Related]
3. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility to antimicrobial drugs of enterotoxin producing strains of Bacteroides fragilis isolated from different countries].
Obuch-Woszczatyński P; Rokosz A; Sawicka-Grzelak A; Pituch H; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2002; 54(3):253-8. PubMed ID: 12632660
[TBL] [Abstract][Full Text] [Related]
5. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
6. [Beta-lactamases with a wide substrate spectrum in gram negative strictly anaerobic rods].
Rokosz A; Sawicka-Grzelak A; Kot K; Pituch H; Meisel-Mikołajczyk F; Luczak M
Med Dosw Mikrobiol; 2000; 52(2):129-37. PubMed ID: 11107787
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
[TBL] [Abstract][Full Text] [Related]
9. [Antibiotic susceptibility and occurrence of ESBL, IBL and MBL in Pseudomonas aeruginosa strains].
Wolska K; Jakubczak A; Soszyńska A
Med Dosw Mikrobiol; 2008; 60(2):111-9. PubMed ID: 18819447
[TBL] [Abstract][Full Text] [Related]
10. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
Schaumann R; Petzold S; Fille M; Rodloff AC
Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
[TBL] [Abstract][Full Text] [Related]
11. [Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].
Rokosz A; Sawicka-Grzelak A; Kot K; Meszaros J; Łuczak M
Med Dosw Mikrobiol; 2001; 53(2):167-75. PubMed ID: 11757426
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
[TBL] [Abstract][Full Text] [Related]
13. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
[TBL] [Abstract][Full Text] [Related]
14. [Occurrence of beta-lactamase type ESBL in rods of the Serratia species].
Ulatowska B; Czajkowski H; Gospodarek E; Mikucka A
Med Dosw Mikrobiol; 2000; 52(1):17-24. PubMed ID: 11107776
[TBL] [Abstract][Full Text] [Related]
15. [Identification and susceptibility to antimicrobial agents of strictly anaerobic bacteria isolated from hospitalized patients].
Kot K; Rokosz A; Sawicka-Grzelak A; łuczak M
Med Dosw Mikrobiol; 2002; 54(3):233-41. PubMed ID: 12632658
[TBL] [Abstract][Full Text] [Related]
16. [Use of new methods for detection of beta-lactamases with extended-spectrum substrates (ESBLs)].
Rokosz A; Sawicka-Grzelak A; Mészáros J; łuczak M
Med Dosw Mikrobiol; 2002; 54(3):225-31. PubMed ID: 12632657
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
18. [Detection of beta-lactamases in the Bacteroides fragilis group].
Martin C; Dubreuil L; Sedallian A; Romond C
Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
[TBL] [Abstract][Full Text] [Related]
19. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL
Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
